Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer.
暂无分享,去创建一个
Issam El Naqa | Luis Souhami | James Coates | I. El Naqa | L. Souhami | J. Coates | N. Ybarra | S. Faria | A. Jeyaseelan | M. David | F. Cury | M. Duclos | Sergio Faria | Norma Ybarra | Marie Duclos | Marc David | Fabio Cury | Asha K Jeyaseelan
[1] C. Fiorino,et al. Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Johannes A Langendijk,et al. Multivariate modeling of complications with data driven variable selection: guarding against overfitting and effects of data set size. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] I El Naqa,et al. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose–volume outcome relationships , 2006, Physics in medicine and biology.
[4] J. Deasy,et al. Radiation dose-volume effects in radiation-induced rectal injury. , 2010, International journal of radiation oncology, biology, physics.
[5] Andrea Ottolenghi,et al. Biological mechanisms of normal tissue damage: importance for the design of NTCP models. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Yoshiya Yamada,et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. , 2006, The Journal of urology.
[7] R. Mohan,et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. , 1991, International journal of radiation oncology, biology, physics.
[8] Daniel Gomez,et al. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. , 2011, International journal of radiation oncology, biology, physics.
[9] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[10] A. Markoe,et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). , 2002, International journal of radiation oncology, biology, physics.
[11] Joseph O Deasy,et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.
[12] Joos V Lebesque,et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. , 2006, International journal of radiation oncology, biology, physics.
[13] S. Bentzen. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology , 2006, Nature Reviews Cancer.
[14] Mehmet Koyutürk,et al. An optimization framework for unsupervised identification of rare copy number variation from SNP array data , 2009, Genome Biology.
[15] Hon Keung Tony Ng,et al. Statistical Methods in Epidemiology , 2011, International Encyclopedia of Statistical Science.
[16] Paul Martin Putora,et al. Informatics in Radiation Oncology , 2015 .
[17] J. Catto,et al. Gastrointestinal toxicity following radiotherapy for prostate cancer: a ring of fire. , 2011, European urology.
[18] M. Hurles,et al. Copy number variation in human health, disease, and evolution. , 2009, Annual review of genomics and human genetics.
[19] Sambasivarao Damaraju,et al. Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer , 2006, Clinical Cancer Research.
[20] E. Yorke,et al. Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.
[21] J. Lyman. Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.
[22] H. A. Kahn,et al. Statistical Methods in Epidemiology , 1989 .
[23] J. Lamerdin,et al. Rare microsatellite polymorphisms in the DNA repair genesXRCC1, XRCC3 andXRCC5 associated with cancer in patients of varying radiosensitivity , 1997, Somatic cell and molecular genetics.
[24] S. S. Wilks. The Large-Sample Distribution of the Likelihood Ratio for Testing Composite Hypotheses , 1938 .
[25] J. Cappelleri,et al. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience , 2005, International Journal of Impotence Research.
[26] J. Deasy,et al. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. , 2006, International journal of radiation oncology, biology, physics.
[27] Kenneth J. White,et al. Obtaining any Wald statistic you want , 1986 .
[28] G. Dianov,et al. XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. , 2004, Nucleic acids research.
[29] Barry S Rosenstein,et al. Establishment of a radiogenomics consortium. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] Johannes A Langendijk,et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] Paul Schellhammer,et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.
[32] A. Tomkinson,et al. Nucleosome Disruption by DNA Ligase III-XRCC1 Promotes Efficient Base Excision Repair , 2011, Molecular and Cellular Biology.
[33] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[34] H. Shu,et al. Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] Dan T. L. Jones,et al. Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] J. Deasy,et al. Radiation dose-volume effects and the penile bulb. , 2010, International journal of radiation oncology, biology, physics.
[37] Joseph O Deasy,et al. CERR: a computational environment for radiotherapy research. , 2003, Medical physics.
[38] L Souhami,et al. Controversies in prostate cancer radiotherapy: consensus development. , 2001, The Canadian journal of urology.
[39] Claudio Fiorino,et al. Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] Steve Webb,et al. Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397) , 2009, Physics in medicine and biology.
[41] Radhe Mohan,et al. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. , 2013, International journal of radiation oncology, biology, physics.
[42] Christopher A Peters,et al. Association of Single Nucleotide Polymorphisms in SOD2, XRCC1 and XRCC3 with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer , 2008, Radiation research.
[43] W. Shih,et al. Late gastrointestinal toxicities following radiation therapy for prostate cancer. , 2011, European urology.
[44] 高橋 聡,et al. Common Terminology Criteria for Adverse Events (CTCAE) v3.0による胃癌術後合併症の解析 , 2006 .
[45] P. Levendag,et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE) , 2003 .
[47] G. Shenouda,et al. Hypofractionated radiotherapy for favorable risk prostate cancer. , 2010, International journal of radiation oncology, biology, physics.
[48] L J Peters,et al. A new isoeffect curve for change in dose per fraction. , 1983, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[49] M. Sydes,et al. Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397) , 2010, International journal of radiation oncology, biology, physics.
[50] C. Andreassen. Searching for genetic determinants of normal tissue radiosensitivity--are we on the right track? , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[51] Joos V Lebesque,et al. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer. , 2012, International journal of radiation oncology, biology, physics.
[52] U. Langsenlehner,et al. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[53] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.